series-a
Stage
1
Investors
About
Tiumbio is a biopharmaceutical company developing novel synthetic and biological therapeutics targeting rare and intractable diseases, including immune-oncology, fibrotic diseases, endometriosis, and hemophilia.
Explore Tiumbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.